- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 24 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.28: 4 residues within 4Å:- Chain A: A.706, E.1072, K.1073, N.1074
Ligand excluded by PLIPNAG.29: 1 residues within 4Å:- Chain A: N.657
Ligand excluded by PLIPNAG.30: 2 residues within 4Å:- Chain A: N.616, Q.644
Ligand excluded by PLIPNAG.31: 4 residues within 4Å:- Chain A: N.280, E.281, N.282
- Chain C: K.558
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain A: Y.28, N.30, N.61
Ligand excluded by PLIPNAG.33: 4 residues within 4Å:- Chain A: H.146, N.148, N.149, M.153
Ligand excluded by PLIPNAG.34: 3 residues within 4Å:- Chain A: Q.115, E.132, N.165
Ligand excluded by PLIPNAG.35: 1 residues within 4Å:- Chain A: N.234
Ligand excluded by PLIPNAG.36: 4 residues within 4Å:- Chain C: A.706, E.1072, K.1073, N.1074
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain C: N.657
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain C: N.616, Q.644
Ligand excluded by PLIPNAG.39: 4 residues within 4Å:- Chain C: N.280, E.281, N.282
- Chain E: K.558
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain C: Y.28, N.30, N.61
Ligand excluded by PLIPNAG.41: 4 residues within 4Å:- Chain C: H.146, N.148, N.149, M.153
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain C: Q.115, E.132, N.165
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain C: N.234
Ligand excluded by PLIPNAG.44: 4 residues within 4Å:- Chain E: A.706, E.1072, K.1073, N.1074
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain E: N.657
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain E: N.616, Q.644
Ligand excluded by PLIPNAG.47: 4 residues within 4Å:- Chain A: K.558
- Chain E: N.280, E.281, N.282
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain E: Y.28, N.30, N.61
Ligand excluded by PLIPNAG.49: 3 residues within 4Å:- Chain E: N.148, N.149, M.153
Ligand excluded by PLIPNAG.50: 3 residues within 4Å:- Chain E: Q.115, E.132, N.165
Ligand excluded by PLIPNAG.51: 1 residues within 4Å:- Chain E: N.234
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Liu, Z. et al., Cryo-EM structure of SARS-CoV-2 D614G S with three ACE2 receptors binding (RB3) in prefusion conformation. To Be Published
- Release Date
- 2025-02-05
- Peptides
- Spike glycoprotein: ACE
Angiotensin-converting enzyme 2: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BC
CE
AB
ED
FF
D
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 24 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Liu, Z. et al., Cryo-EM structure of SARS-CoV-2 D614G S with three ACE2 receptors binding (RB3) in prefusion conformation. To Be Published
- Release Date
- 2025-02-05
- Peptides
- Spike glycoprotein: ACE
Angiotensin-converting enzyme 2: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BC
CE
AB
ED
FF
D